✦ LIBER ✦

6560 POSTER A Phase I Safety and Pharmacokinetic Study of Everolimus, an Oral mTOR Inhibitor, in Subjects With Impaired Hepatic Function

✍ Scribed by Peveling-Oberhag, J.; Zeuzem, S.; Yong, W.R.; Kunz, T.; Paquet, T.; Bouillaud, E.; Urva, S.; Anak, O.; Seilami, D.; Kobalava, Z.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacokinetic study of cap

✍ Maarten J. Deenen, Heinz-Josef Klümpen, Dick J. Richel, Rolf W. Sparidans, Marie 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 299 KB

The oral mTOR inhibitor RAD001 (everolim

✍ Ahmad Awada; Fatima Cardoso; Christel Fontaine; Luc Dirix; Jacques De Grève; Chr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 175 KB

385 POSTER A phase I safety, pharmacokin

✍ K.P. Papadopoulos; J.R. Infante; A.F. Wong; L.A. Kunkel; A. Patnaik; M. Goldston 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

359 Phase Ib and pharmacokinetic studies

✍ M. Campone; V. Levy; V. Delecroix; E. Bourbouloux; D. Bootle; C. Tanaka; N. Shan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 144 KB

5066 POSTER A Clinical Study to Assess P

✍ Abbas-Borhan, R.; Chalon, S.; Leister, C.; Gaaloul, M. El; Parks, V.; Sonnichsen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Phase I safety, pharmacokinetic, and pha

✍ Markman, B.; Tabernero, J.; Krop, I.; Shapiro, G. I.; Siu, L.; Chen, L. C.; Mita 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 362 KB